These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2656626

  • 21. [The evaluation of cefmetazole in clinical use. The study group of cefmetazole in clinical use].
    Si C, Tian G.
    Zhonghua Nei Ke Za Zhi; 1996 Oct; 35(10):668-72. PubMed ID: 9592326
    [Abstract] [Full Text] [Related]

  • 22. Comparative intraoperative concentrations of two cephalosporins with activity against anaerobic bacteria.
    DiPiro JT, Connors JE, Bowden TA, Stanfield JA, Lampert BM, Stewart JT.
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():89-95. PubMed ID: 2722728
    [Abstract] [Full Text] [Related]

  • 23. [Efficiency of cefmetazole and cefoxitin in the treatment of sepsis caused by gram-negative bacteria].
    Noguerado A, García-Monzón C, Martínez MC, Isasia T, Padilla B, Arribas I, Moreno MJ, Jiménez ML.
    Rev Clin Esp; 1988 Mar; 182(5):250-2. PubMed ID: 3041494
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative clinical study of cefpiramide (SM-1652) and cefmetazole for the treatment of respiratory tract infections by a double-blind method].
    Kobayashi H, Kitamoto O, Saito A, Kato Y, Tomizawa M, Nakayama I, Abe M, Ujiie A, Kinoshita Y, Yajima O.
    Kansenshogaku Zasshi; 1983 Jul; 57(7):587-629. PubMed ID: 6418838
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials.
    Schentag JJ.
    Pharmacotherapy; 1991 Jul; 11(1):2-19. PubMed ID: 2020609
    [Abstract] [Full Text] [Related]

  • 27. Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.
    Tan JS, File TM.
    Am J Med; 1984 Dec 21; 77(6A):51-2. PubMed ID: 6097125
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Double-blind clinical study on cefotetan and cefmetazole in treating respiratory tract infections].
    Jpn J Antibiot; 1983 Feb 21; 36(2):316-68. PubMed ID: 6343663
    [Abstract] [Full Text] [Related]

  • 30. Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
    Barriere SL.
    Am J Hosp Pharm; 1991 Oct 21; 48(10):2146-50. PubMed ID: 1781469
    [Abstract] [Full Text] [Related]

  • 31. [Clinical studies of cefoxitin with special reference to pulmonary suppuration and pyothorax with respiratory tract infection].
    Ito T.
    Jpn J Antibiot; 1984 Sep 21; 37(9):1679-84. PubMed ID: 6512984
    [Abstract] [Full Text] [Related]

  • 32. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL, Schell RF, Carr BB, Kowalsky SF, Tillotson JR.
    Drug Intell Clin Pharm; 1982 Apr 21; 16(4):306-12. PubMed ID: 7067621
    [Abstract] [Full Text] [Related]

  • 33. Cefmetazole treatment of intra-abdominal infection.
    Holloway WJ, Winslow DL, Reinhardt JF.
    J Antimicrob Chemother; 1989 Apr 21; 23 Suppl D():47-54. PubMed ID: 2722723
    [Abstract] [Full Text] [Related]

  • 34. Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
    Brook I.
    Clin Infect Dis; 1993 Jun 21; 16 Suppl 4():S425-6. PubMed ID: 8324161
    [No Abstract] [Full Text] [Related]

  • 35. [Evaluation of clinical efficacy of a cephem antibiotic, cefmetazole, in inflammatory infections of the upper respiratory tract].
    Fujimaki Y, Kawamura S, Sugita R, Ohsawa H, Deguchi K, Kojima T, Ichikawa M.
    Jpn J Antibiot; 1982 Jun 21; 35(6):1511-22. PubMed ID: 6752466
    [Abstract] [Full Text] [Related]

  • 36. Clinical experience with cefoxitin sodium.
    Shah PM, Helm EB, Stille W.
    J Antimicrob Chemother; 1978 Jul 21; 4(B):117-25. PubMed ID: 357376
    [No Abstract] [Full Text] [Related]

  • 37. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
    Ohkawa M, Hirano S, Nakashima T, Tokunaga S, Motoi I, Kuroda K, Nakamura T, Iwasa Y, Tajika E, Sakai A, Haginaka T, Kanda S, Kato M, Hasegawa M, Mikawa I, Ikeda A, Shoda R, Ejiri S, Takemae K, Kojima A, Nakajima S, Miyagi T, Ohtaki M, Kitagawa K, Kameda K, Taya T, Okumura R, Shimada K, Kobayashi T, Nango C, Okasho A, Fujita Y, Miyazaki K, Tsukahara K, Kawaguchi S, Tanaka T, Ueno K, Watanabe K.
    Jpn J Antibiot; 1983 Jan 21; 36(1):129-49. PubMed ID: 6341653
    [Abstract] [Full Text] [Related]

  • 38. [Effectiveness of cefmetazole in the treatment of infectious-inflammatory urologic diseases].
    Derevianko II, Perepanova TS, Kotliarova GA, Kondrat'eva EM.
    Antibiot Khimioter; 1995 Jan 21; 40(1):37-40. PubMed ID: 7605130
    [Abstract] [Full Text] [Related]

  • 39. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime.
    Hughes CE, Johnson CC, Bamberger DM, Reinhardt JF, Peterson LR, Mulligan ME, Gerding DN, George WL, Finegold SM.
    Clin Ther; 1987 Jan 21; 10 Suppl A():36-49. PubMed ID: 3319172
    [Abstract] [Full Text] [Related]

  • 40. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
    Crane VS.
    Hosp Formul; 1991 Apr 21; 26(4):302-6, 309-10. PubMed ID: 10109799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.